According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034.
Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...
According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031.
Systemic infection treatments combat infections that have spread throughout the bloodstream...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek